These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3127674)

  • 21. Acceptability and efficacy of purified vero-cell rabies vaccine in Thai children exposed to rabies.
    Chutivongse S; Supich C; Wilde H
    Asia Pac J Public Health; 1988; 2(3):179-84. PubMed ID: 3179096
    [No Abstract]   [Full Text] [Related]  

  • 22. Intradermal use of human diploid cell vaccine for preexposure rabies immunizations.
    Dreesen DW; Sumner JW; Brown J; Kemp DT
    J Am Vet Med Assoc; 1982 Dec; 181(12):1519-23. PubMed ID: 7161170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis against rabies.
    Wilde H; Hemachudha T
    N Engl J Med; 2005 Apr; 352(15):1608-10; author reply 1608-10. PubMed ID: 15832456
    [No Abstract]   [Full Text] [Related]  

  • 24. An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India.
    Sampath G; Reddy SV; Rao ML; Rao YU; Palaniappan C
    Vaccine; 2005 Jan; 23(7):897-900. PubMed ID: 15603890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment.
    Ubol S; Phanuphak P
    Clin Exp Immunol; 1986 Mar; 63(3):491-7. PubMed ID: 3708902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific activity of concentrated and purified cell culture rabies vaccine (CPCRV) from the strain Vnukovo -32-107 in an experiment with therapeutical immunization of humans.
    Selimov M; El'bert L; Aksenova T; Klyueva E; Gribencha L; Movsesyants A; Antonova L; Kamenetskaya I; Mishchenko N; Krupenin L; Bugayeva M; Yaretskaya V; Pyaeva A
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):83-94. PubMed ID: 7086124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention of rabies].
    Pille ER
    Feldsher Akush; 1982; 47(10):12-6. PubMed ID: 6925527
    [No Abstract]   [Full Text] [Related]  

  • 28. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
    Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM
    Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How far can the antigen content of tissue culture rabies vaccine be reduced safely?
    Wilde H; Hemachudha T
    Vaccine; 2006 Mar; 24(10):1489. PubMed ID: 16280188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rabies preventive treatment. Protective measures in rabies infections].
    Ott H
    Dtsch Med Wochenschr; 1967 Nov; 92(46):2125-7. PubMed ID: 6073923
    [No Abstract]   [Full Text] [Related]  

  • 32. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of purified vero-cell rabies vaccine in patients bitten by rabid animals in India.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1994 Sep; 26(3):139-46. PubMed ID: 7868836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Need of rabies vaccine after a course of rabies vaccination.
    Paul Y
    Indian Pediatr; 1999 Feb; 36(2):199. PubMed ID: 10713823
    [No Abstract]   [Full Text] [Related]  

  • 35. Who cares?--despite RTI act.
    Chaturvedi S; Randive B
    Natl Med J India; 2007; 20(1):47-8. PubMed ID: 17561555
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of bat bites.
    Commun Dis Rep CDR Wkly; 1996 Sep; 6(37):319. PubMed ID: 8854452
    [No Abstract]   [Full Text] [Related]  

  • 37. Guillain-Barre syndrome following antirabies vaccine.
    Udawat H; Nayak R; Chaudhary HR; Goyal RK
    J Assoc Physicians India; 2000 May; 48(5):538-9. PubMed ID: 11273154
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reduction of the classical schedule of rabies vaccine treatment].
    Gamet A; Atanasiu P
    Presse Med (1893); 1971 May; 79(24):1113-4. PubMed ID: 5580539
    [No Abstract]   [Full Text] [Related]  

  • 39. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM; Leggat PA; Williams ML
    Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
    Matha IS; Salunke SR
    Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.